We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corporation Unit
FLACU

Delisted

FLACU was delisted on the 22nd of November, 2022.

Back to rankings

14 hedge funds and large institutions have $31M invested in Frazier Lifesciences Acquisition Corporation Unit in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $31.3M → $31M (-$304K)

18% less funds holding

Funds holding: 17 → 14 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WCMNY
Westchester Capital Management (New York)
New York
-$650K
2
GCL
Glazer Capital LLC
New York
-$284K
3
UBS Group
UBS Group
Switzerland
-$51.5K
4
WAM
Wolverine Asset Management
Illinois
-$8K
5
MF
Magnetar Financial
Illinois
-$1.43K
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$15.2M – – –
RCM
2
RA Capital Management
Massachusetts
$9.98M – – –
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$3.04M – – –
HF
4
HRT Financial
New York
$866K – – –
TAL
5
TIG Advisors LLC
New York
$679K – – –
SIM
6
Sandia Investment Management
Massachusetts
$305K – – –
WCMNY
7
Westchester Capital Management (New York)
New York
$199K -$650K -64,474 -76%
MTCM
8
Mint Tower Capital Management
Netherlands
$199K – – –
WMSA
9
Weiss Multi-Strategy Advisers
New York
$164K – – –
Walleye Capital
10
Walleye Capital
New York
$149K – – –
GCIA
11
Gabelli & Co Investment Advisers
New York
$104K – – –
AM
12
Anqa Management
New York
$59K – – –
UBS Group
13
UBS Group
Switzerland
$8K -$51.5K -5,110 -87%
MF
14
Magnetar Financial
Illinois
– -$1.43K -145,000 Closed
GCL
15
Glazer Capital LLC
New York
– -$284K -28,788 Closed
WAM
16
Wolverine Asset Management
Illinois
– -$8K -860 Closed

FLACU Hedge Fund Activity: Q3 2022 in Review

14 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q3 2022, worth a combined $31M — down 0.97% from $31.3M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of FLACU and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Westchester Capital Management (New York), cutting an estimated $650K.

  • 14 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q3 2022, down from 17 in Q2 2022.
  • Funds reported $31M of Frazier Lifesciences Acquisition Corporation Unit stock for Q3 2022, down 0.97% quarter-over-quarter.
  • 0 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q3 2022 and 3 closed out, a net change of -3 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q3 2022 was Westchester Capital Management (New York), an estimated $650K sold.

Based on aggregated 13F filings for Q3 2022.